Definium Therapeutics股价上涨,因其治疗焦虑症的药物达到了后期临床试验的目标

路透中文
Aug 12
BUZZ-<a href="https://laohu8.com/S/DFTX">Definium Therapeutics</a>股价上涨,因其治疗焦虑症的药物达到了后期临床试验的目标

8月12日 - ** 生物技术公司 Definium TherapeuticsDFTX.O)的股价在盘前交易中上涨 22.2%,至 50.01 美元

** 该公司 (link) 表示,在一项晚期临床研究中,其基于LSD的实验性口服药显著减轻了广泛性焦虑障碍(GAD)成年患者的焦虑症状,达到了试验的主要目标

** 服用该药物的患者在第12周时,标准焦虑评分量表得分下降了11.6分,而服用安慰剂的患者得分仅下降了6.2分——DFTX

** 大多数副作用为轻度至中度且暂时性,主要发生在服药当天,且未出现自杀念头增加的情况 - DFTX

** 截至上一交易日收盘,DFTX今年以来累计上涨205.5%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10